InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Reine Allan, Chief Financial Officer. Officer active across 1 companies, notably Foghorn Therapeutics Inc.. In total, 2 filings have been logged. The latest transaction was disclosed on 9 August 2021 — Levée d'options. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations2 total
€85,22326,892 shares@ €3.1691100.0% of flow
Common Stock
SEC:0001562180-21-005284·
€85,22326,892 shares@ €3.16910.028% mcap50.0% of flow
Common Stock
SEC:0001562180-21-005284:0·
2 of 2 declarations
About Reine Allan
Allan Reine is the Chief Financial Officer at Foghorn Therapeutics Inc. He is responsible for financial management and strategic planning. Allan plays a vital role in optimizing financial resources and achieving the company's objectives.
